Skip to main content

Table 4 Adverse Events

From: Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study

Adverse Event FP (n = 64) F (n = 65) p-value
All Gr. Gr. 3–4 All Gr. Gr. 3–4
No. (%) No. (%) No. (%) No. (%) All Gr. Gr. 3–4
Leukocytopenia 40 (63) 11 (17) 23 (35) 5 (8) < 0.01 0.10
Neutropenia 39 (61) 23 (36) 17 (26) 7 (11) < 0.01 < 0.01
Anemia 51 (80) 12 (19) 37 (57) 15 (23) < 0.01 0.55
Thrombocytopenia 37 (58) 3 (5) 9 (14) 0 (0) < 0.01 0.08
Febrile neutropenia 3 (5) 3 (5) 3 (5) 3 (5) 0.98 0.98
Anorexia 42 (66) 10 (16) 37 (57) 17 (26) 0.31 0.14
Nausea 40 (63) 3 (5) 34 (52) 1 (2) 0.24 0.30
Vomiting 18 (28) 1 (2) 23 (35) 2 (3) 0.38 0.57
Diarrhea 16 (25) 3 (5) 18 (28) 1 (2) 0.73 0.30
Stomatitis 14 (22) 1 (2) 7 (11) 0 (0) 0.09 0.31
Fatigue 27 (42) 2 (3) 27 (42) 3 (5) 0.94 0.66
Sensory neuropathy 24 (38) 1 (2) 0 (0) 0 (0) < 0.01 0.31